Visual Acuity Converter
Convert between visual acuity formats for diabetic retinopathy and ophthalmology documentation
🧮 Visual Acuity Converter — Formula
🩺 Screening tools only — not diagnostic. Positive screens require full clinical evaluation.
📌Bailey IL, Lovie JE. Am J Optom 1976 / WHO Visual Impairment Classification
📊 Quick Reference
| Input / Parameter | Description | Example Value |
|---|---|---|
| Item responses | Each scored item on the clinical scale (0–N) | PHQ-9 item 1: score 2 |
| Total score | Sum of all item scores | PHQ-9 total: 14 |
| Severity category | Classification per validated cutoffs | Moderate depression |
| Interpretation | Clinical action recommended by score range | Warrants clinical evaluation |
| Scale range | Minimum to maximum possible score | PHQ-9: 0–27 |
ℹ️ About This Calculator
The Visual Acuity Converter is a standardised neurological or psychiatric assessment tool that quantifies clinical signs, cognitive function, or symptom severity using a validated, reproducible scoring system. Standardised assessment tools are essential in neurology and psychiatry because they transform inherently subjective clinical observations into objective, comparable numbers that can be tracked over time, communicated between providers, and used to guide treatment decisions.
Neurological and psychiatric conditions account for an estimated 30% of the global burden of disease (WHO) and are frequently under-diagnosed in primary care. Validated screening tools like PHQ-9 and GAD-7 have been shown in multiple studies to significantly improve detection rates for depression and anxiety compared to unstructured clinical interviews. Similarly, tools like the NIHSS and GCS provide standardised neurological assessment that enables consistent communication across clinical teams and documents the baseline against which recovery or deterioration is measured.
The scoring method for this tool — including each item, response anchors, and published cutoff thresholds — is described in the Formula section below. Proper item-by-item scoring is critical: a single misscored item can change the total by enough to shift the severity category, potentially changing clinical action. For clinician-administered scales (GCS, NIHSS), training in standardised administration improves reliability. For patient-reported tools (PHQ-9, GAD-7), read each question exactly as written and allow the patient to answer without leading prompts.
Critical limitation: screening and assessment tools are not diagnostic instruments. A PHQ-9 score of 15 identifies a patient who is likely experiencing moderate-to-severe depressive symptoms — it does not diagnose major depressive disorder, rule out bipolar disorder, or determine the cause of the depression. A positive screen mandates a structured clinical interview using DSM-5 criteria before any treatment decision. Similarly, a high GCS does not exclude focal neurological injury — always perform a structured neurological examination.
All calculations run in your browser only — no patient data is stored or transmitted. For mental health tools in particular, this privacy protection is important: patients should feel confident that their responses to screening questions about mood, suicidal ideation, or psychiatric symptoms are not logged or shared.
For scores indicating high risk — such as PHQ-9 item 9 >0 (suicidal ideation), NIHSS suggesting major stroke, GCS ≤8 indicating coma, or CIWA-Ar >15 suggesting severe withdrawal — immediate clinical action is required. Consult a psychiatrist, neurologist, or the relevant emergency specialist without delay. These tools provide structured assessment data; the clinical response must be proportionate to the result.
📌Clinical Reference: Bailey IL, Lovie JE. Am J Optom 1976 / WHO Visual Impairment Classification
📋 How to Use This Calculator
- 1
Select or administer the assessment
For clinician-administered scales (GCS, NIHSS), perform the structured assessment at the bedside using the standardised protocol. For patient-reported tools (PHQ-9, GAD-7), have the patient complete the questionnaire.
- 2
Enter each item response
Input the score or response for each individual item. Refer to the standardised anchor descriptions to ensure accurate scoring — small differences in scoring can change the severity category.
- 3
Calculate the total score
The tool sums item scores and displays the total. For multi-domain scales, domain scores are also calculated separately.
- 4
Apply validated severity cutoffs
Review the output against published cutoffs (e.g., PHQ-9 ≥10 = moderate depression; GCS ≤8 = coma). The tool displays the appropriate classification alongside the score.
- 5
Document and plan follow-up
Record the score and date in the clinical notes. For screening tools, a positive result triggers referral for comprehensive assessment — the score alone is not diagnostic.
🎯 When to Use This Calculator
Acute stroke assessment
Apply NIHSS immediately on stroke presentation to quantify neurological deficit, guide tPA eligibility determination, and document baseline severity for monitoring.
Depression and anxiety screening
Administer PHQ-9 and GAD-7 at each clinic visit to screen for depression and anxiety, monitor treatment response, and document progress over time.
Trauma and altered consciousness assessment
Use GCS in the ED and ICU to grade consciousness level, guide airway management decisions (GCS ≤8), and communicate severity between providers.
Alcohol withdrawal risk assessment
Calculate CIWA-Ar score to determine severity of alcohol withdrawal, guide benzodiazepine dosing, and assess the need for ICU-level monitoring.
Sleepiness and cognitive screening
Use Epworth Sleepiness Scale to screen for excessive daytime sleepiness and MMSE for cognitive decline — both guide referrals for sleep studies or neuropsychological evaluation.
💡 Clinical Pro Tips
Psychiatric screening tools are dimensional assessments, not diagnostic instruments. A PHQ-9 score of 15 (moderately severe) does not diagnose major depressive disorder — it indicates the need for a structured clinical interview using DSM-5 criteria to confirm diagnosis and rule out bipolar disorder.
The Glasgow Coma Scale should always be recorded as its three components (E/V/M), not just the total. "GCS 8" is ambiguous — "GCS E2V2M4" communicates exactly what is and is not preserved. For intubated patients, record the verbal component as "T" (e.g., E3VTM5).
The NIHSS is highly assessor-dependent and should be performed by trained, certified observers for research and treatment decisions. For non-certified observers, it is a useful clinical framework but scores may vary by up to 2–3 points between raters.
For PHQ-9 and GAD-7, the clinical significance of score changes matters more than absolute values. A reduction of ≥5 points in PHQ-9 is generally considered a clinically meaningful response to treatment. Track changes at 4–6-week intervals to assess treatment response.
More Neurology & Psychiatry Tools
PHQ-9 Depression Screening
Score the PHQ-9 questionnaire for depression screening and severity classification.
GAD-7 Anxiety Score
Calculate GAD-7 score for generalized anxiety disorder severity assessment.
NIH Stroke Scale (NIHSS)
Quantify stroke severity using the 15-item NIH Stroke Scale neurological assessment.
Epworth Sleepiness Scale
Assess daytime sleepiness severity using the 8-item Epworth Sleepiness Scale.
MMSE / MoCA Cognitive Screen
Screen for cognitive impairment and dementia using MMSE and MoCA scoring guides.
Lithium Dose Calculator
Calculate lithium dosing for bipolar disorder targeting therapeutic serum levels.
Your input is processed locally in your browser and is never stored, transmitted, or shared with any server. See our Privacy Policy.